{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:45:28Z","timestamp":1765485928129,"version":"3.48.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":273,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.ctarc.2025.101012","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:26:59Z","timestamp":1759343219000},"page":"101012","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Correlation between TTF-1 expression and EGFR mutations in moroccan lung adenocarcinoma: A prospective six-year study"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4297-3380","authenticated-orcid":false,"given":"Sara","family":"Boukansa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismail","family":"Mouhrach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima El","family":"Agy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mokhtar El","family":"Mekhtoume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laila","family":"Bouguenouch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mounia","family":"Serraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bouchra","family":"Amara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yassine","family":"Ouadnouni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Smahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Badreeddine","family":"Alami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nawfel","family":"Mellas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zineb","family":"Benbrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hinde El","family":"Fatemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ctarc.2025.101012_bib0001","first-page":"17","article-title":"Cancer statistics","volume":"73","author":"Siegel Mph","year":"2023","journal-title":"CA. Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.ctarc.2025.101012_bib0002","first-page":"45","article-title":"Epidemiology of lung cancer","volume":"25","author":"Thandra","year":"2021","journal-title":"Contemp. Oncol."},{"issue":"7","key":"10.1016\/j.ctarc.2025.101012_bib0003","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1200\/JCO.20.01605","article-title":"Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer","volume":"39","author":"Borghaei","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ctarc.2025.101012_bib0004","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/cncr.34565","article-title":"A phase 2 trial of chemotherapy plus pembrolizumab in patients with advanced non-small cell lung cancer previously treated with a PD-1 or PD-L1 inhibitor: Big Ten Cancer Research Consortium BTCRC-LUN15-029","volume":"129","author":"Salous","year":"2023","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2025.101012_bib0005","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1016\/j.cllc.2021.10.009","article-title":"Overall Treatment Strategy for Patients With Metastatic NSCLC With Activating EGFR Mutations","volume":"23","author":"Hayashi","year":"2022","journal-title":"Clin. Lung Cancer"},{"issue":"31","key":"10.1016\/j.ctarc.2025.101012_bib0006","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1200\/JCO.21.02911","article-title":"Updated Analysis of NEJ009: Gefitinib-Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated EGFR","volume":"40","author":"Miyauchi","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ctarc.2025.101012_bib0007","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0167-4781(96)00180-7","article-title":"Regulation of Clara cell secretory protein gene transcription by thyroid transcription factor-1","volume":"1350","author":"Zhang","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"issue":"11","key":"10.1016\/j.ctarc.2025.101012_bib0008","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1002\/j.1460-2075.1990.tb07574.x","article-title":"Thyroid nuclear factor 1 (TTF-1) contains a homeodomain and displays a novel DNA binding specificity","volume":"9","author":"Guazzi","year":"1990","journal-title":"EMBO J"},{"issue":"1","key":"10.1016\/j.ctarc.2025.101012_bib0009","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1042\/CS20080068","article-title":"Thyroid transcription factor-1 (TTF-1\/Nkx2.1\/TITF1) gene regulation in the lung","volume":"116","author":"Boggaram","year":"2009","journal-title":"Clin. Sci. (Lond)."},{"issue":"9","key":"10.1016\/j.ctarc.2025.101012_bib0010","first-page":"4650","article-title":"TTF-1 and EGFR expression are related to EGFR mutation in lung adenocarcinoma","volume":"11","author":"Chen","year":"2018","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"1","key":"10.1016\/j.ctarc.2025.101012_bib0011","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics10010025","article-title":"TTF-1\/p63-Positive Poorly Differentiated NSCLC: A Histogenetic Hypothesis from the Basal Reserve Cell of the Terminal Respiratory Unit","volume":"10","author":"Cabibi","year":"2020","journal-title":"Diagnostics"},{"issue":"5","key":"10.1016\/j.ctarc.2025.101012_bib0012","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.humpath.2014.01.005","article-title":"The utility of a novel triple marker (combination of TTF1, napsin A, and p40) in the subclassification of non-small cell lung cancer","volume":"45","author":"Ao","year":"2014","journal-title":"Hum. Pathol."},{"issue":"22","key":"10.1016\/j.ctarc.2025.101012_bib0013","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.7150\/jca.26830","article-title":"Prognostic Impact of TTF-1 Expression in Non-Squamous Non-Small-Cell Lung Cancer: A Meta-Analysis","volume":"9","author":"Kim","year":"2018","journal-title":"J. Cancer"},{"issue":"43","key":"10.1016\/j.ctarc.2025.101012_bib0014","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.20095","article-title":"EGFR TKI as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer","volume":"8","author":"Nan","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.ctarc.2025.101012_bib0015","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.21037\/tlcr-2020-13","article-title":"EGFR tyrosine kinase inhibitors (TKIs) for adjuvant therapy of early-stage non-small cell lung cancer (NSCLC): ready for the clinic?","volume":"9","author":"Steuer","year":"2020","journal-title":"Transl. Lung Cancer Res."},{"issue":"2","key":"10.1016\/j.ctarc.2025.101012_bib0016","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.cllc.2016.07.003","article-title":"Phase II Study of the EGFR-TKI Rechallenge With Afatinib in Patients With Advanced NSCLC Harboring Sensitive EGFR Mutation Without T790M: Okayama Lung Cancer Study Group Trial OLCSG 1403","volume":"18","author":"Oda","year":"2017","journal-title":"Clin. Lung Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2025.101012_bib0017","first-page":"362","article-title":"Analyzing EGFR mutations and their association with clinicopathological characteristics and prognosis of patients with lung adenocarcinoma","volume":"16","author":"Zhou","year":"2018","journal-title":"Oncol. Lett."},{"issue":"4","key":"10.1016\/j.ctarc.2025.101012_bib0018","doi-asserted-by":"crossref","first-page":"450","DOI":"10.21037\/tlcr.2018.05.14","article-title":"Lung cancer in never smokers\u2014the East Asian experience","volume":"7","author":"Zhou","year":"2018","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.ctarc.2025.101012_bib0019","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.semcancer.2019.09.015","article-title":"Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer","volume":"61","author":"Harrison","year":"2020","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.ctarc.2025.101012_bib0020","first-page":"1","article-title":"Prevalence of EGFR Mutations and Clinico-Pathological Characteristics of Chilean Lung Cancer Patients,\u201d Asian Pac","volume":"20","author":"Gejman","year":"2019","journal-title":"J. Cancer Prev."},{"issue":"1","key":"10.1016\/j.ctarc.2025.101012_bib0021","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.1365-2559.2000.00801.x","article-title":"Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B","volume":"36","author":"Kaufmann","year":"2000","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.ctarc.2025.101012_bib0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095479","article-title":"The Relationship between TTF-1 Expression and EGFR Mutations in Lung Adenocarcinomas","volume":"9","author":"Shanzhi","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ctarc.2025.101012_bib0023","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2022-001492","article-title":"Differential clinicopathological features, treatments and outcomes in patients with Exon 19 deletion and Exon 21 L858R EGFR mutation-positive adenocarcinoma non-small-cell lung cancer","volume":"10","author":"Batra","year":"2023","journal-title":"BMJ Open Respir. Res."},{"key":"10.1016\/j.ctarc.2025.101012_bib0024","doi-asserted-by":"crossref","DOI":"10.1017\/S0016672314000032","article-title":"Spectrum of somatic EGFR, KRAS, BRAF, PTEN mutations and TTF-1 expression in Brazilian lung cancer patients","volume":"96","author":"Carneiro","year":"2014","journal-title":"Genet. Res. (Camb)."},{"issue":"2","key":"10.1016\/j.ctarc.2025.101012_bib0025","article-title":"Correlation of Thyroid Transcription Factor-1 Expression with EGFR Mutations in Non-Small-Cell Lung Cancer: A Meta-Analysis","volume":"55","author":"Kim","year":"2019","journal-title":"Medicina (Kaunas)."},{"issue":"2","key":"10.1016\/j.ctarc.2025.101012_bib0026","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/JTO.0b013e3182381515","article-title":"High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR\/TTF-1 expressions, and clinical features","volume":"7","author":"Sun","year":"2012","journal-title":"J. Thorac. Oncol."},{"issue":"7","key":"10.1016\/j.ctarc.2025.101012_bib0027","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1038\/bjc.2013.511","article-title":"EGFR mutational status in a large series of Caucasian European NSCLC patients: data from daily practice","volume":"109","author":"Gahr","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.ctarc.2025.101012_bib0028","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3747\/co.21.2148","article-title":"Relationship of thyroid transcription factor 1 to EGFR status in non-small-cell lung cancer","volume":"21","author":"Sheffield","year":"2014","journal-title":"Curr. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2025.101012_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-019-5792-0","article-title":"Thyroid transcription factor-1 as a prognostic indicator for stage IV lung adenocarcinoma with and without EGFR-sensitizing mutations","volume":"19","author":"Park","year":"2019","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.ctarc.2025.101012_bib0030","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4132\/jptm.2021.05.10","article-title":"Correlation of TTF-1 immunoexpression and EGFR mutation spectrum in non\u2013small cell lung carcinoma","volume":"55","author":"Nakra","year":"2021","journal-title":"J. Pathol. Transl. Med."},{"issue":"12","key":"10.1016\/j.ctarc.2025.101012_bib0031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168795","article-title":"An Analysis of EGFR Mutations among 1506 Cases of Non-Small Cell Lung Cancer Patients in Guangxi, China","volume":"11","author":"Wei","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ctarc.2025.101012_bib0032","first-page":"2469","article-title":"Thyroid transcription factor-1 expression is significantly associated with mutations in exon 21 of the epidermal growth factor receptor gene in Chinese patients with lung adenocarcinoma","volume":"8","author":"Zhao","year":"2015","journal-title":"Onco. Targets. Ther."},{"issue":"10","key":"10.1016\/j.ctarc.2025.101012_bib0033","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.1016\/j.jtho.2016.08.029","article-title":"P1.08: Updated Analysis of Global Epidemiology of EGFR Mutation in Advanced Non-Small Cell Lung Cancer: Track: Prevention, Early Detection, Epidemiology and Tobacco Control","volume":"11","author":"Castillo-Fernandez","year":"2016","journal-title":"J. Thorac. Oncol."},{"issue":"4","key":"10.1016\/j.ctarc.2025.101012_bib0034","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.currproblcancer.2018.11.003","article-title":"Clinicopathologic characteristics and EGFR mutations in lung cancer patients aged below 45 years","volume":"43","author":"Xia","year":"2019","journal-title":"Curr. Probl. Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2025.101012_bib0035","first-page":"25","article-title":"Prognostic value of TTF-1 expression in patients with non-small cell lung cancer: a meta-analysis","volume":"2","author":"Zhan","year":"2013","journal-title":"Transl. Cancer Res."},{"issue":"1","key":"10.1016\/j.ctarc.2025.101012_bib0036","first-page":"145","article-title":"Combined assessment of EGFR pathway-related molecular markers and prognosis of NSCLC patients","volume":"100","author":"Ruiz","year":"2008","journal-title":"Br. J. Cancer 2009 1001"},{"issue":"1","key":"10.1016\/j.ctarc.2025.101012_bib0037","first-page":"36","article-title":"Targeted therapy for non-small cell lung cancer: current standards and the promise of the future","volume":"4","author":"Chan","year":"2015","journal-title":"Transl. Lung Cancer Res."},{"issue":"13","key":"10.1016\/j.ctarc.2025.101012_bib0038","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/1759-7714.14858","article-title":"Precision targeted therapy for EGFR mutation-positive NSCLC: Dilemmas and coping strategies","volume":"14","author":"Meng","year":"2023","journal-title":"Thorac. Cancer"}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294225001480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294225001480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:36:58Z","timestamp":1765485418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294225001480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":38,"alternative-id":["S2468294225001480"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2025.101012","relation":{},"ISSN":["2468-2942"],"issn-type":[{"type":"print","value":"2468-2942"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation between TTF-1 expression and EGFR mutations in moroccan lung adenocarcinoma: A prospective six-year study","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2025.101012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101012"}}